Recombinant Anti-CD15 x Anti-CD64 Bispecific Antibody (IgG-Fv) (BSGV-032)

Recombinant Anti-CD15 x Anti-CD64 Bispecific Antibody (IgG-Fv) is formed by an Immunoglobulin G (IgG) and a fragment variable Fv region, in which the Fc of IgG is engineered by KIH. The Fv region of an anti-CD15 antibody variable domain is fused to the C terminal of an IgG of anti-CD64 antibody, or vice versa. The format retains desired characteristics of intact antibodies. This BsAb can retarget neutrophils to tumor cells. It is designed for the research of Leukemia therapy.

Datasheet INQUIRY

Specifications

Targets

CD15 & CD64

Type

IgG-Fv

Species Reactivity

Human

Application

FuncS; Promising therapeutic agent

Related Disease

Leukemia

Targets

Target 1

CD15

Gene ID

2526

UniProt ID

P22083

Alternative Names

FUT4; fucosyltransferase 4; LeX; CD15; ELFT; FCT3A; FUTIV; SSEA-1; FUC-TIV; 3-FAL; 3-fucosyl-N-acetyllactosamine; stage-specific embryonic antigen-1; Lewis X; X-hapten

Target 2

CD64

Gene ID

2209

UniProt ID

P12314

Alternative Names

FCGR1A; Fc fragment of IgG receptor Ia; CD64; FCRI; CD64A; IGFR1; Cluster of Differentiation 64; FcγRI; FCGR1B; FCGR1C; immunoglobulin G Fc receptor high affinity I; Fc gamma RI

Our products and services are for research use only, and not for use in diagnostic or therapeutic procedures.

Online Inquiry

Customer Reviews and Q&As

There are currently no customer reviews or questions for Recombinant Anti-CD15 x Anti-CD64 Bispecific Antibody (IgG-Fv) (BSGV-032). Click the button below to contact us or submit your feedback about this product.

Recombinant Anti-CD15 x Anti-CD64 Bispecific Antibody (IgG-Fv) (CAT#: BSGV-032)

Specifications

Targets

Customer Reviews and Q&As